NCT06565546View on ClinicalTrials.gov

CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 29, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
Ventral Hernia
Interventions
OTHER

Opioid pain medication prescribed based on CYP2D6 genotype testing PLUS Acetaminophen and Gabapentin

CYP2D6 genotype testing for assessment of medication metabolism to guide prescription of postoperative pain medication

OTHER

Acetaminophen and Gabapentin: standard postoperative pain medications

Participants will receive standard postoperative pain medications

Trial Locations (1)

32209

RECRUITING

University of Florida Jacksonville, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER